跳至主要内容
临床试验/NCT06879808
NCT06879808已完成不适用

The Effect of Color Therapy on Depression, Stress, Anxiety and Quality of Life in Hemodialysis Patients: A Randomized Controlled Study

Erzincan Binali Yildirim Universitesi1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Depression Anxiety Stress-21 scale (DASS-21)

研究概览

简要总结

This study was conducted to examine the effect of color therapy on depression, stress, anxiety and quality of life in hemodialysis patients.

详细描述

Many patients on hemodialysis treatment require hemodialysis, which requires hospitalization three times a week for four hours each dialysis session. Therefore, practices such as color therapy may be useful in the management of psychological symptoms in these patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
18 Weeks 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Be on hemodialysis treatment for at least 6 months,
  • •No sleeping pills or sedative medication,
  • •No physical or cognitive impairment that prevents them from understanding the education and no diagnosis of a psychiatric illness,
  • •The patient or someone living in the same household with the patient is literate,
  • •Patients have no vision problems,
  • •Patients must be 18 years of age or older.

排除标准

  • •Being on hemodialysis treatment for less than 6 months,
  • •Taking sleeping pills or sedative medication,
  • •Being diagnosed with a physical illness or cognitive impairment or psychiatric illness that prevents understanding the education provided,
  • •Illiteracy of the patient and relatives,
  • •Patients have vision problems,
  • •Refusing to participate in the research,
  • •Under 18 years of age

研究组 & 干预措施

Color therapy group

Experimental

group doing color therapy

干预措施: Color therapy (Other)

No color therapy group

No Intervention

group not doing color therapy

结局指标

主要结局

Depression Anxiety Stress-21 scale (DASS-21)

时间窗: 8 week

The 21-question DASS scale used in the study was taken by Henry and Crawford. This scale (DASS-21) has 7 questions each to measure the dimensions of depression, stress and anxiety. The scale is a 4-point Likert-type scale, coded as 0 "not applicable to me", 1 "somewhat applicable to me", 2 "generally applicable to me", and 3 "completely applicable to me".

Short Form-12 (SF-12) Quality of Life Scale

时间窗: 8 week

Ware et al. decided to develop a more practical form of the SF-36 that could be administered in a shorter time and developed the SF-12, which contains the same sub-dimensions as the SF-36 by reducing the number of questions. In addition to the fact that the SF-12 was created in such a way that the same component summary scores can be obtained as the SF-36, the fact that it contains fewer items and therefore has a shorter administration time provides a great advantage. Although it has been demonstrated that the SF-36 scale has sufficient validity and reliability in studies conducted in both patient and normal sample groups in our country, the validity and reliability study of the Turkish form of the SF-12, which was developed as a shorter alternative to the SF-36, was attempted. Similar to SF-36, SF-12 consists of 8 sub-dimensions and 12 items including physical functioning (2 items), physical role (2 items), body pain (1 item), general health (1 item), energy (1 item), social function

次要结局

未报告次要终点

研究者

发起方
Erzincan Binali Yildirim Universitesi
申办方类型
Other
责任方
Principal Investigator
主要研究者

Safiye Yanmış

Assistant Professor

Erzincan Binali Yildirim Universitesi

研究点 (1)

Loading locations...

相似试验